Cost minimization analysis of different growth hormone pen devices based on time-and-motion simulations
<p>Abstract</p> <p>Background</p> <p>Numerous pen devices are available to administer recombinant Human Growth Hormone (rhGH), and both patients and health plans have varying issues to consider when selecting a particular product and device for daily use. Therefore, the...
Saved in:
Main Authors: | Kim Jaewhan (Author), Haak Sandra W (Author), Nickman Nancy A (Author) |
---|---|
Format: | Book |
Published: |
BMC,
2010-04-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Cost-consequence analysis for human recombinant growth hormone (r-hGH) treatment administered via different devices in children with growth hormone deficiency in Italy
by: Foo J, et al.
Published: (2019) -
Human and financial resource needs for universal access to WHO-PEN interventions for diabetes and hypertension care in Eswatini: results from a time-and-motion and bottom-up costing study
by: Harsh Vivek Harkare, et al.
Published: (2024) -
Pen in the Park / Pen Parkta A Resistance Fairytale / Bir Direniş Masalı
by: Meseri, Raşel
Published: (2014) -
Pen in the Park / Pen Parkta A Resistance Fairytale / Bir Direniş Masalı
by: Meseri, Raşel
Published: (2014) -
A PEN INJECTOR FOR SELF-ADMINISTRATION OF FOLLITROPIN ALPHA SOLUTION WITH A MINIMAL DOSE INCREMENT OF 5 IU
by: A. B. Podkorytov, et al.
Published: (2018)